MENU

BIIB Biogen Forecast, Technical & Fundamental Analysis

a manufacturer of therapies for people living with neurological, autoimmune and hematologic disorders

BIIB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
BIIB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

BIIB is expected to report earnings to fall 16.18% to $3.42 per share on January 30

Biogen BIIB Stock Earnings Reports
Q4'24
Est.
$3.42
Q3'24
Beat
by $0.31
Q2'24
Beat
by $1.27
Q1'24
Beat
by $0.24
Q4'23
Missed
by $0.23
The last earnings report on October 30 showed earnings per share of $4.08, beating the estimate of $3.77. With 1.38M shares outstanding, the current market capitalization sits at 31.34B.
A.I. Advisor
published General Information

General Information

a manufacturer of therapies for people living with neurological, autoimmune and hematologic disorders

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Biotechnology
Address
225 Binney Street
Phone
+1 617 679-2000
Employees
7570
Web
https://www.biogen.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA463.0226.79
+6.14%
Tesla
GME29.441.45
+5.18%
GameStop Corp
BTC.X106029.7200001731.023400
+1.66%
Bitcoin cryptocurrency
AAPL251.042.91
+1.17%
Apple
SPY606.792.58
+0.43%
SPDR® S&P 500® ETF Trust

BIIB and Stocks

Correlation & Price change

A.I.dvisor tells us that BIIB and OGN have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BIIB and OGN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIIB
1D Price
Change %
BIIB100%
+0.31%
OGN - BIIB
33%
Poorly correlated
-4.71%
PFE - BIIB
31%
Poorly correlated
-1.29%
NVS - BIIB
30%
Poorly correlated
-0.60%
AZN - BIIB
28%
Poorly correlated
-0.53%
JNJ - BIIB
24%
Poorly correlated
-1.89%
More